About

Calibrate focuses on sustainable weight loss by improving metabolic health instead of traditional dieting methods. Their program combines gradual habit changes with medication that targets underlying biological factors. This approach is based on extensive research and claims to be the first to achieve a 15% sustained weight loss in real-world settings. Calibrate operates on a subscription model, often supported by employers as part of employee wellness programs, but individuals can also subscribe. The program utilizes GLP-1 medications, which help reduce inflammation, regulate digestion, and enhance metabolic function. Calibrate differentiates itself by offering a non-restrictive program that is easy to maintain, along with a money-back guarantee for users who do not see results. The company's goal is to promote long-term health and wellness through effective weight management.

Simplify's Take

What believers are saying

• Growing interest in personalized medicine boosts demand for Calibrate's tailored approach.
• Employers investing in wellness programs create opportunities for Calibrate's corporate expansion.
• Value-based care trends align with Calibrate's evidence-based, measurable health outcomes.

What critics are saying

• Patient complaints about GLP-1 access could harm Calibrate's reputation and finances.
• Sale to Madryn Asset Management may disrupt operations and affect employee morale.
• Economic downturns could reduce employer wellness program investments, impacting revenue.

What makes Calibrate unique

• Calibrate combines FDA-approved medication with a holistic curriculum for weight loss.
• The program offers 1:1 virtual coaching sessions for personalized support.
• Calibrate claims 15% sustained weight loss outside clinical trials, a unique achievement.

Help us improve and share your feedback! Did you find this helpful?

YesNo